Medical Research

Weill Cancer Hub West Unites to Revolutionize Cancer Care
Clinical & Pharma Weill Cancer Hub West Unites to Revolutionize Cancer Care

In an unprecedented move aimed at transforming the landscape of cancer research and patient care, the Weill Cancer Hub West has been officially launched. This innovative, collaborative initiative has emerged as a response to the global cancer crisis, with an impressive $100 million matching grant

DEA Cannabis Quotas Hinder Medical Research Progress
Clinical & Pharma DEA Cannabis Quotas Hinder Medical Research Progress

Cannabis, once dismissed as a menace, is now being widely considered for its potential therapeutic benefits. However, the advancement of cannabis research has been significantly impeded by the U.S. Drug Enforcement Administration’s (DEA) rigorous control over its production for study purposes. By

Can Dr. Brett Kissela Revolutionize UCGNI's Neurological Care?
Clinical & Pharma Can Dr. Brett Kissela Revolutionize UCGNI's Neurological Care?

The University of Cincinnati Gardner Neuroscience Institute (UCGNI) has unveiled a significant change in its leadership with the appointment of Dr. Brett Kissela as the new director. This development is more than just a change of guard; it represents a strategic pivot toward advancing neurological

Can Brain Resting States Unlock Secrets to Neuro Disorders?
Clinical & Pharma Can Brain Resting States Unlock Secrets to Neuro Disorders?

In the quest to unravel the complexities of the human brain, researchers often focus on activities associated with alert states, overlooking the intricate workings during rest. Recent groundbreaking studies are redefining this approach, revealing a treasure trove of information encoded in the

Can AI Accelerate Alzheimer's Clinical Trials?
Clinical & Pharma Can AI Accelerate Alzheimer's Clinical Trials?

The integration of artificial intelligence into Alzheimer's research has ignited significant interest as researchers seek innovative ways to enhance the efficiency and effectiveness of clinical trials. One study spearheaded by researchers at the University of Cambridge has gained attention,

How Will Derek Cummings Revolutionize Infectious Disease Research?
Clinical & Pharma How Will Derek Cummings Revolutionize Infectious Disease Research?

The world of infectious disease research has seen transformative changes, and Derek Cummings is at the forefront of these innovations. As he returns to Johns Hopkins University as the Bloomberg Distinguished Professor of Infectious Disease Dynamics, his imminent contribution promises to reshape the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later